Cargando…
Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer
Women with polycystic ovary syndrome (PCOS) are more likely to develop endometrial cancer (EC). The molecular mechanisms which increase the risk of EC in PCOS are unclear. Derangements in lipid metabolism are associated with EC, but there have been no studies, investigating if this might increase th...
Autores principales: | Shafiee, Mohamad Nasir, Ortori, Catharine A., Barrett, David A., Mongan, Nigel P., Abu, Jafaru, Atiomo, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370092/ https://www.ncbi.nlm.nih.gov/pubmed/32635401 http://dx.doi.org/10.3390/ijms21134753 |
Ejemplares similares
-
Lipidomic analysis of plasma samples from women with polycystic ovary syndrome
por: Haoula, Zeina, et al.
Publicado: (2014) -
Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome
por: Atiomo, William, et al.
Publicado: (2017) -
Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota
por: Prakash, Amog, et al.
Publicado: (2022) -
Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas
por: Alqutami, Fatma, et al.
Publicado: (2023) -
Proteomic Biomarkers of Preterm Birth Risk in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Biomarker Database Integration
por: Galazis, Nicolas, et al.
Publicado: (2013)